Aktis Oncology, Inc. (AKTS)

Last Closing Price: 16.40 (2026-11-19)

Common Equity (Quarterly)

Common Equity: The sum of all common equity items.

Aktis Oncology, Inc. (AKTS) had Common Equity of $458.87M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$3.90M
$-29.94M
--
$3.90M
$38.65M
$-34.75M
$4.81M
$-29.94M
$-29.94M
$-29.94M
$-29.94M
$-29.94M
$-29.94M
$-34.75M
$-35.71M
55.65M
55.65M
$-0.54
$-0.54
Balance Sheet Financials
$499.89M
$15.37M
$32.60M
$532.48M
$35.16M
--
$38.45M
$73.61M
Common Equity
$458.87M
$458.87M
$458.87M
55.78M
Cash Flow Statement Financials
$-70.88M
$-237.99M
$339.41M
$38.93M
$69.47M
$30.54M
$9.69M
--
--
Fundamental Metrics & Ratios
14.22
--
--
--
--
100.00%
-889.81%
-889.81%
--
-766.68%
-766.68%
$-74.77M
--
--
--
0.01
--
--
--
-6.52%
-6.52%
-5.62%
-6.52%
$8.23
$-1.34
$-1.27